One-year weight reduction with semaglutide or liraglutide in clinical practice
Importance Limited data are available on long-term weight loss achieved with semaglutide
or liraglutide for type 2 diabetes (T2D) or obesity in clinical practice. Objective To document …
or liraglutide for type 2 diabetes (T2D) or obesity in clinical practice. Objective To document …
[HTML][HTML] Weight-centric prevention of cancer
Background The link between excess adiposity and carcinogenesis has been well
established for multiple malignancies, and cancer is one of the main contributors to obesity …
established for multiple malignancies, and cancer is one of the main contributors to obesity …
Early‐and later‐stage persistence with antiobesity medications: a retrospective cohort study
Objective The study's objective was to examine the percentage of patients with an initial
antiobesity medication (AOM) fill who were persistent with AOM at 3, 6, and 12 months and …
antiobesity medication (AOM) fill who were persistent with AOM at 3, 6, and 12 months and …
Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills
Aim To characterize factors associated with the receipt of anti‐obesity medication (AOM)
prescription and fill. Materials and Methods This retrospective cohort study used electronic …
prescription and fill. Materials and Methods This retrospective cohort study used electronic …
Cost-effectiveness of pharmacotherapy for the treatment of obesity in adolescents
F Lim, BK Bellows, SX Tan, Z Aziz… - JAMA Network …, 2023 - jamanetwork.com
Importance Antiobesity pharmacotherapy is recommended for adolescents ages 12 years
and older with obesity. Several medications have been approved by the US Food and Drug …
and older with obesity. Several medications have been approved by the US Food and Drug …
Trends and Disparities in Newer GLP1 Receptor Agonist Initiation among Real-World Adult Patients Eligible for Obesity Treatment
Aims: To characterize trends in the initiation of newer anti-obesity medications (AOMs) and
determine factors associated with their use among obese/overweight populations. Materials …
determine factors associated with their use among obese/overweight populations. Materials …
Medically Supervised Weight Loss and Effects of Anti-Obesity Medications
AJ Sheer, WT Donahoo, CN Johnson-Mann - The SAGES Manual of …, 2024 - Springer
The treatment of obesity dates back centuries; however, it was only in the twentieth century
that focused efforts began with the introduction of the first true anti-obesity medications …
that focused efforts began with the introduction of the first true anti-obesity medications …